Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt

BSE1557.15141.55 (+10 %)

PREV CLOSE ( ) 1415.60

OPEN PRICE ( ) 1490.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 78224

TODAY'S LOW / HIGH ( )1440.00 1557.15

52 WK LOW / HIGH ( )421 1580

NSE1558.55141.65 (+10 %)

PREV CLOSE( ) 1416.90

OPEN PRICE ( ) 1490.00

BID PRICE (QTY) 1558.55 (96600)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1616248

TODAY'S LOW / HIGH( ) 1441.00 1558.55

52 WK LOW / HIGH ( )420 1582.95

Chairman	Habil Khorakiwala
Managing Director	Murtaza Khorakiwala
Company Secretary	Rashmi Mamtura
Executive Director	Huzaifa Khorakiwala
Non Executive Independent Director	Vinesh Kumar Jairath Akhilesh Gupta Amelia Fernandes Ahmad Javed
Non Independent & Non Executive Director	Zahabiya Khorakiwala

Incorporation Year : 08-07 1999

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006 .

Phone : 0240-6632222 / 6694444

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE